candicine: from trunk bark of Galipea officinalis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Galipea | genus | [no description available] | Rutaceae | A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 23135 |
| CHEMBL ID | 1186075 |
| CHEBI ID | 3350 |
| SCHEMBL ID | 9561478 |
| MeSH ID | M0395339 |
| Synonym |
|---|
| brn 4133224 |
| candicin |
| benzeneethanaminium, 4-hydroxy-n,n,n-trimethyl- |
| 4-hydroxy-n,n,n-trimethylbenzeneethanaminium |
| smr000386994 |
| MLS001048976 , |
| ammonium, (p-hydroxyphenethyl)trimethyl- |
| 6656-13-9 |
| candicine |
| 2-(4-hydroxyphenyl)ethyl-trimethylazanium |
| NCGC00246201-01 |
| CHEMBL1186075 |
| 5v2tj5h9z8 , |
| unii-5v2tj5h9z8 |
| 2-(4-hydroxyphenyl)-n,n,n-trimethylethanaminium |
| 2-(4-hydroxyphenyl)ethyl-trimethylazanium;iodide |
| bdbm73699 |
| 2-(4-hydroxyphenyl)ethyl-trimethylammonium;iodide |
| cid_15127809 |
| 2-(4-hydroxyphenyl)ethyl-trimethyl-ammonium;iodide |
| 2-(4-hydroxyphenyl)ethyl-trimethyl-azanium;iodide |
| CHEBI:3350 , |
| SCHEMBL9561478 |
| 2-(4-hydroxyphenyl)ethyl-trimethyl-ammonium |
| benzeneethanaminium,4-hydroxy-n,n,n-trimethyl- |
| AKOS030573561 |
| Q5031710 |
| FT-0737753 |
| DTXSID80901642 |
| [2-(4-hydroxyphenyl)ethyl]trimethylazanium |
| STL581350 |
| E87162 |
| Class | Description |
|---|---|
| primary amine | A compound formally derived from ammonia by replacing one hydrogen atom by a hydrocarbyl group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.06) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||